Task: Answer the multiple-choice question.
Question: Which drug exhibits a -2.070% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] CN1C(=O)C(=Cc2ccccc2OCCOc2ccc([N+](=O)[O-])cc2)C(=O)N(C)C1=O
[b] COC(=O)CCc1nc2c(C#N)c(-c3ccc(Cl)cc3)ccn2n1
Answer: b. COC(=O)CCc1nc2c(C#N)c(-c3ccc(Cl)cc3)ccn2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)CCc1nc2c(C#N)c(-c3ccc(Cl)cc3)ccn2n1
COC(=O)CCc1nc2c(C#N)c(-c3ccc(Cl)cc3)ccn2n1
methyl 3-[7-(4-chlorophenyl)-8-cyano-[1,2,4]triazolo[1,5-a]pyridin-2-yl]propanoate